Iodide symporter gene expression in normal and transformed rat thyroid cells

Area of Science:

• Molecular Biology
• Oncology
• Endocrinology

Background:

• Sodium-iodide symporter (NIS) activity is crucial for radioiodine detection and treatment of metastatic thyroid cancer.
• Loss of NIS activity in thyroid tissues significantly impairs radioiodine therapy efficacy.
• Understanding factors affecting NIS activity is vital for improving thyroid cancer management.

Purpose of the Study:

• To investigate the role of specific oncogene abnormalities in altering Na+/I- symporter (NIS) activity in thyroid cells.
• To determine if oncogene activation is responsible for reduced iodide uptake in thyroid cancer.
• To explore the mechanisms underlying NIS activity changes in transformed thyroid cells.

Main Methods:

• Northern blot analysis was used to assess NIS gene expression.
• Expression levels were compared between normal thyroid cells and various oncogene-transformed cell lines.
• Cell lines with differing degrees of malignancy and iodide uptake ability were utilized.

Main Results:

• Thyroid-stimulating hormone (TSH) and forskolin dose-dependently and time-dependently upregulated NIS gene expression in normal cells.
• Insulin and TPA partially inhibited NIS gene expression in normal cells.
• Oncogene-transformed cell lines exhibited reduced NIS mRNA levels, with some showing near-complete absence of expression.

Conclusions:

• Oncogene activation plays a significant role in modulating iodide uptake ability in thyroid tumoral cells.
• Diverse mechanisms are implicated in the oncogene-dependent loss of NIS activity in transformed thyroid cells.
• These findings highlight the complex interplay between oncogenes and NIS function in thyroid cancer.